Gilead Could Be The Winner From Washington State's Winner-Take-All Hep C Proposal [Seeking Alpha]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Seeking Alpha
Gilead Could Be The Winner From Washington State's Winner-Take-All Hep C Proposal The states of Louisiana and Washington are bringing a Netflix (NASDAQ: NFLX model GILD What Washington is attempting to do has been commonly done for other services/products. It creates an RFP (request for Proposal) process for drug manufacturers to compete for their business. While this idea is nothing new nor novel, it comes with issues that most aren't considering. The market for Hepatitis C providers has been shaken up since Gilead's Sovaldi hit the market in 2013, and now, the most common Hep C products for consumption are: Drug Company Approval Mavyret AbbVie Aug.-17 Vosevi July-17 Epclusa June-16 Zepatier Merck Jan.-16 Daklinza* Bristol-Myers Squibb July-15 Harvoni Oct.-14 Dec.-13 *Daklinza taken in combination with Sovaldi On a pure numbers basis, Gilead would be the most logical company to win these contracts as it has the most drugs currently being used, but that is not usually how RFP processe
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- Bristol Myers Squibb Swings To Quarterly Loss, After String Of Multi-Billion Acquisitions [Yahoo! Finance]Yahoo! Finance
- Bristol-Myers (BMY) Q1 Loss Narrower Than Expected, Sales Beat [Yahoo! Finance]Yahoo! Finance
- Why Bristol Myers Squibb Stock Is Sinking Today [Yahoo! Finance]Yahoo! Finance
- Bristol Myers (BMY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]Yahoo! Finance
- Bristol Myers Squibb (BMY) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
BMY
Earnings
- 4/25/24 - Miss
BMY
Sec Filings
- 4/25/24 - Form 10-Q
- 4/25/24 - Form 8-K
- 4/22/24 - Form DEFA14A
- BMY's page on the SEC website